Furthermore, TPCA-1, a dual inhibitor of STAT3 and NF-κB signaling, was employed to inhibit the activation of NF-κB/STAT3 signaling in AOM/DSS-induced UCCRC mice. This evidence concerns the gene NFKB1 and infectious otitis media.